Condition: Healthy Volunteers · Sponsor: Meiji Pharma USA Inc.
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants
This description comes directly from the study's public registry record.
Meiji Pharma USA Inc. Study Lead · +1 201-777-7133 · mpu.clinical@meiji.com
Always discuss trial participation with your own doctor first.
| Scientia Clinical Reserch Ltd | Sydney, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07422207